According to FIGO 2023 endometrial cancer staging, a tumour that invades the outer half of the myometrium with positive cervical stroma involvement is now staged as:

• A Stage IB (FIGO 2023)
• B Stage II (FIGO 2023) ✓
• C Stage IIIC1 (FIGO 2023)
• D Stage IIA (FIGO 2023)

Explanation

In the revised FIGO 2023 staging, Stage II endometrial cancer includes tumour that invades the stroma of the cervix but has not extended beyond the uterus (equivalent to the old Stage IIB from 2009 staging). The 2023 revision retains the Stage II designation for cervical stromal invasion. Stage IB in 2023 refers to outer half myometrial invasion without cervical involvement, and Stage IIIC1 refers to pelvic lymph node metastasis.

Reference: Shaw's Textbook of Gynaecology, 17th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.